These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8242859)
1. Increased mutagenicity of 1,2-dibromo-3-chloropropane and tris(2,3-dibromopropyl)phosphate in Salmonella TA100 expressing human glutathione S-transferases. Simula TP; Glancey MJ; Söderlund EJ; Dybing E; Wolf CR Carcinogenesis; 1993 Nov; 14(11):2303-7. PubMed ID: 8242859 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and mutagenicity of selectively methylated analogs of tris(2,3-dibromopropyl)phosphate and 1,2-dibromo-3-chloropropane. Omichinski JG; Søderlund EJ; Bausano JA; Dybing E; Nelson SD Mutagenesis; 1987 Jul; 2(4):287-92. PubMed ID: 3325760 [TBL] [Abstract][Full Text] [Related]
3. Mutagen activation of 1,2-dibromo-3-chloropropane by cytosolic glutathione S-transferases and microsomal enzymes. Miller GE; Brabec MJ; Kulkarni AP J Toxicol Environ Health; 1986; 19(4):503-18. PubMed ID: 3537323 [TBL] [Abstract][Full Text] [Related]
4. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites. Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285 [TBL] [Abstract][Full Text] [Related]
5. Human glutathione S-transferase-expressing Salmonella typhimurium tester strains to study the activation/detoxification of mutagenic compounds: studies with halogenated compounds, aromatic amines and aflatoxin B1. Simula TP; Glancey MJ; Wolf CR Carcinogenesis; 1993 Jul; 14(7):1371-6. PubMed ID: 8330352 [TBL] [Abstract][Full Text] [Related]
6. Lack of mammalian mutagenicity of the potent bacterial mutagen tris(2,3-dibromopropyl) phosphate and its metabolite 2-bromoacrolein. van Beerendonk GJ; Klein JC; Tijdens RB; Lichtenauer-Kaligis EG; Tasseron-de Jong JG; Meerman JH Mutat Res; 1998 Jul; 415(3):201-11. PubMed ID: 9714806 [TBL] [Abstract][Full Text] [Related]
7. Detection and mechanism of formation of the potent direct-acting mutagen 2-bromoacrolein from 1,2-dibromo-3-chloropropane. Omichinski JG; Soderlund EJ; Dybing E; Pearson PG; Nelson SD Toxicol Appl Pharmacol; 1988 Feb; 92(2):286-94. PubMed ID: 3277317 [TBL] [Abstract][Full Text] [Related]
8. Different mechanisms are involved in DNA damage, bacterial mutagenicity and cytotoxicity induced by 1,2-dibromo-3-chloropropane in suspensions of rat liver cells. Holme JA; Søderlund EJ; Brunborg G; Omichinski JG; Bekkedal K; Trygg B; Nelson SD; Dybing E Carcinogenesis; 1989 Jan; 10(1):49-54. PubMed ID: 2642751 [TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of bis- and mono-(2,3-dibromopropyl)phosphate, and their salts used as flame retardants, in the Salmonella/microsome system. Nakamura A; Tateno N; Iwata T; Kojima S; Kaniwa M; Kawamura T Mutat Res; 1983 Apr; 117(1-2):1-8. PubMed ID: 6339901 [TBL] [Abstract][Full Text] [Related]
10. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate. Søderlund EJ; Dybing E; Holme JA; Hongslo JK; Rivedal E; Sanner T; Nelson SD Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):20-9. PubMed ID: 3883695 [TBL] [Abstract][Full Text] [Related]
11. Comparative toxicity of (+)-(R)- and (-)-(S)-1,2-dibromo-3-chloropropane. Kouzi SA; Søderlund EJ; Dybing E; Meerman JH; Nelson SD Chirality; 1995; 7(5):359-64. PubMed ID: 7495641 [TBL] [Abstract][Full Text] [Related]
12. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism. Søderlund EJ; Nelson SD; Dybing E Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of 1,2-dibromo-3-chloropropane by glutathione S-transferases. Søderlund EJ; Meyer DJ; Ketterer B; Nelson SD; Dybing E; Holme JA Chem Biol Interact; 1995 Aug; 97(3):257-72. PubMed ID: 7671343 [TBL] [Abstract][Full Text] [Related]
14. Mutagenic activity of halogenated propanes and propenes: effect of bromine and chlorine positioning. Låg M; Omichinski JG; Dybing E; Nelson SD; Søderlund EJ Chem Biol Interact; 1994 Oct; 93(1):73-84. PubMed ID: 8069951 [TBL] [Abstract][Full Text] [Related]
15. Metabolism in vitro of tris(2,3-dibromopropyl)-phosphate: oxidative debromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding. Søderlund EJ; Gordon WP; Nelson SD; Omichinski JG; Dybing E Biochem Pharmacol; 1984 Dec; 33(24):4017-23. PubMed ID: 6508849 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and genotoxicity of the halogenated alkyl compound tris(2,3-dibromopropyl)phosphate. van Beerendonk GJ; Nelson SD; Meerman JH Hum Exp Toxicol; 1994 Dec; 13(12):861-5. PubMed ID: 7718306 [TBL] [Abstract][Full Text] [Related]
17. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein. Nelson SD; Omichinski JG; Iyer L; Gordon WP; Soderlund EJ; Dybing E Biochem Biophys Res Commun; 1984 May; 121(1):213-9. PubMed ID: 6375666 [TBL] [Abstract][Full Text] [Related]
18. Co-culture systems for assessing the stability and genotoxicity of reactive 1,2-dibromo-3-chloropropane (DBCP) metabolites. Søderlund EJ; Brunborg G; Holme JA; Hongslo JK; Nelson SD; Dybing E Mutagenesis; 1991 Jan; 6(1):25-30. PubMed ID: 2038269 [TBL] [Abstract][Full Text] [Related]
19. Contribution of DNA methylation and benzylation to N-nitroso-N-benzyl-methylamine-induced mutagenesis in bacteria: effects of rat liver cytochrome P450 isozymes and glutathione transferases. Lin DX; Malaveille C; Park SS; Gelboin HV; Bartsch H Carcinogenesis; 1990 Sep; 11(9):1653-8. PubMed ID: 2119260 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of bacterial mutagenicity of bifunctional alkylating agents by expression of mammalian glutathione S-transferase. Thier R; Müller M; Taylor JB; Pemble SE; Ketterer B; Guengerich FP Chem Res Toxicol; 1995; 8(3):465-72. PubMed ID: 7578934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]